Boehringer vs Cronus - PIMOMEDIN Trademark Opposition

The TTAB dismissed Boehringer Ingelheim Vetmedica GmbH's trademark opposition against Cronus Pharma LLC's PIMOMEDIN mark with prejudice. The case, filed on June 25, 2025, concluded with a final decision on April 6, 2026, upholding Cronus Pharma's right to register the disputed mark.

This is a routine TTAB decision that applies only to the parties involved and has no broader regulatory implications. Neither party is required to take any action as a result of this decision, which simply concludes the administrative opposition proceeding. No compliance deadlines, penalties, or new obligations are associated with this dismissal.